Zydus Lifesciences Limited has informed the Exchange about newspaper publication of addendum to Public Announcement for Buyback
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has issued an addendum to its existing buyback announcement, published on May 28, 2026 in major newspapers. The company has increased the buyback price from INR 1,150 to INR 1,260 per equity share. Due to this higher price, the maximum number of shares to be bought back has been reduced from 95,65,217 shares to 87,30,158 shares. The buyback represents up to 0.87% of the total paid-up share capital of the company and is being conducted via the tender offer route under SEBI Buy-Back Regulations, 2018. This addendum supplements the original public announcement made on May 21, 2026 and the price revision announced on May 27, 2026.
The increased buyback price offers better returns to shareholders who tender their shares, making the offer more attractive. The reduced quantity means fewer shares will be repurchased at the higher price, maintaining a similar total buyback value while potentially benefiting remaining shareholders through improved per-share economics.